A Study To Examine Safety, Pharmacokinetics, And Pharmacodynamic Of Pf 06412562 In Healthy Males

PHASE1TerminatedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 19, 2015

Primary Completion Date

June 14, 2016

Study Completion Date

June 14, 2016

Conditions

Healthy

Interventions

DRUG

PF-06412562 3mg BID

PF-06412562

DRUG

PF-06412562 15mg BID

PF-06412562

OTHER

Placebo

Trial Locations (3)

Arcadia MRI & Imaging Center, Arcadia

California Clinical Trials Medical Group, Glendale

Glendale Adventist Medical Center, Glendale